Artwork

Kandungan disediakan oleh PER Spectives and PER® Spectives. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh PER Spectives and PER® Spectives atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !

S2 Ep15: PER®Spectives: Advancing Treatment in nAMD and DME with Novel Therapies

18:11
 
Kongsi
 

Manage episode 398780516 series 2987803
Kandungan disediakan oleh PER Spectives and PER® Spectives. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh PER Spectives and PER® Spectives atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
This PER®Spectives™ podcast examines opportunities for extended treatment intervals associated with newer therapies for patients with neovascular age-related macular degeneration or diabetic macular edema. In this podcast, experts Arshad Khanani, MD, Ferhina Ali, MD, and Michael Singer, MD, offer real-world data and personal insights into the use of these agents — and corticosteroid implants for patients with DME — in the clinical setting.
Faculty:
Arshad M. Khanani, MD, MA, FASRS
Managing Partner
Director of Clinical Research and Director of Fellowship
Sierra Eye Associates
Clinical Associate Professor
University of Nevada, Reno School of Medicine
Reno, NV
Ferhina Ali, MD, MPH
Assistant Professor, Vitreoretinal Surgery
Vitreoretinal Surgery Consultant and Fellowship Advisor
Clinical Research Investigator and Vitreoretinal Specialist
Consultant Medical Director
Clinical Instructor
Westchester Medical Center Health Network
Hawthorne, NY
Michael A. Singer, MD
Clinical Associate Professor
University of Texas Health Science Center
Medical Center Ophthalmology Associates, Director of Clinical Research
San Antonio, TX
  continue reading

28 episod

Artwork
iconKongsi
 
Manage episode 398780516 series 2987803
Kandungan disediakan oleh PER Spectives and PER® Spectives. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh PER Spectives and PER® Spectives atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
This PER®Spectives™ podcast examines opportunities for extended treatment intervals associated with newer therapies for patients with neovascular age-related macular degeneration or diabetic macular edema. In this podcast, experts Arshad Khanani, MD, Ferhina Ali, MD, and Michael Singer, MD, offer real-world data and personal insights into the use of these agents — and corticosteroid implants for patients with DME — in the clinical setting.
Faculty:
Arshad M. Khanani, MD, MA, FASRS
Managing Partner
Director of Clinical Research and Director of Fellowship
Sierra Eye Associates
Clinical Associate Professor
University of Nevada, Reno School of Medicine
Reno, NV
Ferhina Ali, MD, MPH
Assistant Professor, Vitreoretinal Surgery
Vitreoretinal Surgery Consultant and Fellowship Advisor
Clinical Research Investigator and Vitreoretinal Specialist
Consultant Medical Director
Clinical Instructor
Westchester Medical Center Health Network
Hawthorne, NY
Michael A. Singer, MD
Clinical Associate Professor
University of Texas Health Science Center
Medical Center Ophthalmology Associates, Director of Clinical Research
San Antonio, TX
  continue reading

28 episod

Усі епізоди

×
 
Loading …

Selamat datang ke Player FM

Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.

 

Panduan Rujukan Pantas

Podcast Teratas